Schedule 13G ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2020-03-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-002390
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Mar 12, 2020
Reporting period
Mar 02, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub